Clinical Trials Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8395-8404
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8395
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Schematic flowchart of the study design. ITT: Intention-to-treat; PP: Per protocol.
  • Citation: Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF, Wu DC, Chuah SK, Taiwan Acid-Related Disease Study Group. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol 2017; 23(47): 8395-8404
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8395.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8395